论文部分内容阅读
有着中国医药行业龙头老大 身份、且近年业绩飞速增 长的哈药集团有限公司,被人称之为“下金蛋的鸡”。眼下,当哈药集团经省市主管部门同意,正在与中央直属大型国企——中国华源集团有限公司商议战略重组之时,“卖掉哈药”、“哈药重组背后有黑洞”一类的议论却从天而降。 哈药是不是被卖掉了?有无黑洞?关心国企、关注哈药的人,在等待答案。
Has the Chinese pharmaceutical industry leader, and the rapid growth in performance in recent years, Harbin Pharmaceutical Group Co., Ltd., known as “the golden eggs under the chicken.” Right now, when Harbin Pharmaceutical Group, under the agreement of provincial and municipal authorities, is in the process of negotiating a strategic reorganization with China Huayuan Group Co., Ltd., a large state-owned enterprise directly under the Central Government, “selling Harbin Pharmaceuticals” and “black hole behind Harbin Pharmaceutical Reorganization” The argument is falling from heaven. Harbin Pharmaceutical is not sold? Are there any black holes? Concerned about state-owned enterprises, concerned about the people of Harbin, waiting for the answer.